Dow Up 0.98% Nasdaq Up 1.72%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
8.57 Down 0.11(1.27%) 12:43PM EDT - Nasdaq Real Time Price
Prev Close:8.68
Open:8.80
Bid:8.58 x 400
Ask:8.59 x 500
1y Target Est:14.00
Beta:1.23
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:8.55 - 8.80
52wk Range:2.05 - 8.99
Volume:586,906
Avg Vol (3m):1,878,290
Market Cap:896.28M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MACKDown 1.27%896.28M
IMMUDown 0.55%338.00M
LRUSF 0.00%N/A
THLDDown 0.33%176.91M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.78
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-1.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback